Pfizer Gets FDA Breakthrough Therapy Designation for Maternal RSV Vaccine
The FDA has granted Breakthrough Therapy designation to Pfizer’s respiratory syncytial vaccine (RSV) candidate, RSVpreF, for the prevention of RSV-associated lower respiratory tract illness in in...